RESEARCH STARTER

Ritalin

Ritalin, the brand name for methylphenidate, is a medication originally synthesized in 1944 and studied for human use in the mid-1950s. Initially prescribed for conditions such as narcolepsy and depression, it gained prominence in the 1960s for its calming effects on children diagnosed with attention-deficit hyperactivity disorder (ADHD). While Ritalin is typically taken orally, alternative methods of administration, such as snorting or intravenous use, have been linked to abuse and can produce euphoric effects similar to those of cocaine. The rise in ADHD diagnoses and the appeal of Ritalin as a cognitive enhancer for academic performance have contributed to increased rates of abuse, particularly among adolescents and college students.

In the United States, estimates suggest that 3 to 10 percent of school-aged children meet the criteria for ADHD, amplifying the drug's availability. While Ritalin can improve focus and attention, it also carries potential risks; short-term side effects may include headache, nausea, and increased anxiety, while long-term use can lead to insomnia and anxiety. Concerns about growth suppression have been debated, and chronic abuse can result in dependence. Understanding the complexities of Ritalin’s use and misuse is essential for informed discussions about its role in treating ADHD and its impact on users.

Full Article

DEFINITION: Ritalin is a central nervous system stimulant that shares many characteristics with amphetamines. It is a controlled substance that is prescribed for attention-deficit hyperactivity disorder and narcolepsy.

  • ALSO KNOWN AS: Methylphenidate
  • STATUS: Legal in the United States and worldwide
  • CLASSIFICATION: Schedule II controlled substance
  • SOURCE: Synthetic substance with no natural sources
  • TRANSMISSION ROUTE: Oral, inhalation, intravenous

History of Use

Although originally synthesized in 1944, Ritalin was not studied for its therapeutic effects in humans until the mid-1950s. Early on, Ritalin was used to treat narcolepsy (a sleep disorder), depression, and chronic fatigue. By the 1960s, it was discovered to produce a calming effect in children who had been diagnosed with symptoms of attention-deficit hyperactivity disorder (ADHD). Between 1995 and 2008, prescriptions for stimulants to treat ADHD increased sixfold. At the same time, misuse or nonmedical use of prescription stimulants also increased. By the 2010s, multiple medical studies found that prescription stimulants, including methylphenidate, were the most effective treatment for ADHD.

When Ritalin is administered orally, its effects are slowed by the gastrointestinal tract, which effectively prevents the user from experiencing a euphoric high. However, when the drug is crushed and snorted or used intravenously, it can lead to intense feelings of pleasure that some have equated with cocaine usage.

According to the 2023 National Survey on Drug Use and Health (NSDUH), 3.9 million people age twelve or older in the US reported previous-year misuse of prescription stimulants, including methylphenidate products. The 2023 NSDUH also reported that young adults between the ages of eighteen and twenty-five had the highest rates of misuse compared to those in other age brackets. Large-scale studies in the 2020s found that the prevalence of using stimulants, including Ritalin, to augment cognition ranged from 20 to 34 percent of college students.

Effects and Potential Risks

Ritalin increases the presence of the neurotransmitter dopamine in the brain by blocking its reuptake by the cells that release it. Short-term adverse effects include headache, nausea, irregular heartbeat, wakefulness, agitation, anxiety, increased blood pressure, and, in rare instances, seizures. Long-term adverse effects include anxiety and sleeplessness. Initial reports of suppression of growth have been placed in doubt by later studies. Dependence can occur with chronic abuse.


Bibliography

Dopelt, Keren, et al. "What Drives the Non-Medical Use of Stimulants Among College Students? The Role of Self-Efficacy and Attitudes: A Cross-Sectional Study of Israeli Undergraduates." European Journal of Investigation in Health, Psychology and Education, vol. 15, no. 7, 2025. MDPI, doi.org/10.3390/ejihpe15070141. Accessed 11 Oct. 2025.

Edinoff, Amber N., et al. "Prescription Stimulants in College and Medical Students: A Narrative Review of Misuse, Cognitive Impact, and Adverse Effects." Psychiatry International, vol. 3, no. 3, 2022, pp. 221-235. MDPI, doi.org/10.3390/psychiatryint3030018. Accessed 11 Oct. 2025.

Iversen, Leslie. Speed, Ecstasy, Ritalin: The Science of Amphetamines. Oxford UP, 2008.

Levinthal, Charles F. Drugs, Behavior, and Modern Society. 9th ed., Pearson, 2023.

"Misuse of Prescription Drugs Research Report: Overview." National Institute on Drug Abuse, 11 Oct. 2011, nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview. Accessed 11 Oct. 2025.

Mosel, Stacy. "Ritalin Addiction: Signs, Effects, and Treatment." American Addiction Centers, 20 Nov. 2024, americanaddictioncenters.org/stimulants/ritalin. Accessed 11 Oct. 2025.

Racine, Eric, and C. Forlini. “Cognitive Enhancement, Lifestyle Choice, or Misuse of Prescription Drugs?” Neuroethics, no. 3, 2010, pp. 1–4.

Rath, Kimberly. "Ritalin Side Effects: What You Should Know." MedicalNewsToday, 9 Sept. 2024, www.medicalnewstoday.com/articles/drugs-ritalin-side-effects. Accessed 11 Oct. 2025.

Raymond, Laurie. "Risks of Stimulant Misuse." Physician Health Services, Inc., www.massmed.org/Physician_Health_Services/Education_and_Resources/Risks_of_Stimulant_Misuse/. Accessed 11 Oct. 2025.

“Signs and Symptoms of Prescription Drug Use.” Narconon, www.narconon.org/drug-abuse/signs-symptoms-prescription-drug-use.html. Accessed 11 Oct. 2025.

"2023 NSDUH Annual National Report." Substance Abuse and Mental Health Services Administration, 30 July 2024, www.samhsa.gov/data/report/2023-nsduh-annual-national-report. Accessed 11 Oct. 2025.

Wilde, Cathy. "Nonprescription Use of Ritalin Linked to Adverse Side Effects, UB Study Finds." UB Now, 17 May 2017, www.buffalo.edu/ubnow/stories/2017/05/thanos-ritalin.html. Accessed 11 Oct. 2025.

Full Article

DEFINITION: Ritalin is a central nervous system stimulant that shares many characteristics with amphetamines. It is a controlled substance that is prescribed for attention-deficit hyperactivity disorder and narcolepsy.

  • ALSO KNOWN AS: Methylphenidate
  • STATUS: Legal in the United States and worldwide
  • CLASSIFICATION: Schedule II controlled substance
  • SOURCE: Synthetic substance with no natural sources
  • TRANSMISSION ROUTE: Oral, inhalation, intravenous

History of Use

Although originally synthesized in 1944, Ritalin was not studied for its therapeutic effects in humans until the mid-1950s. Early on, Ritalin was used to treat narcolepsy (a sleep disorder), depression, and chronic fatigue. By the 1960s, it was discovered to produce a calming effect in children who had been diagnosed with symptoms of attention-deficit hyperactivity disorder (ADHD). Between 1995 and 2008, prescriptions for stimulants to treat ADHD increased sixfold. At the same time, misuse or nonmedical use of prescription stimulants also increased. By the 2010s, multiple medical studies found that prescription stimulants, including methylphenidate, were the most effective treatment for ADHD.

When Ritalin is administered orally, its effects are slowed by the gastrointestinal tract, which effectively prevents the user from experiencing a euphoric high. However, when the drug is crushed and snorted or used intravenously, it can lead to intense feelings of pleasure that some have equated with cocaine usage.

According to the 2023 National Survey on Drug Use and Health (NSDUH), 3.9 million people age twelve or older in the US reported previous-year misuse of prescription stimulants, including methylphenidate products. The 2023 NSDUH also reported that young adults between the ages of eighteen and twenty-five had the highest rates of misuse compared to those in other age brackets. Large-scale studies in the 2020s found that the prevalence of using stimulants, including Ritalin, to augment cognition ranged from 20 to 34 percent of college students.

Effects and Potential Risks

Ritalin increases the presence of the neurotransmitter dopamine in the brain by blocking its reuptake by the cells that release it. Short-term adverse effects include headache, nausea, irregular heartbeat, wakefulness, agitation, anxiety, increased blood pressure, and, in rare instances, seizures. Long-term adverse effects include anxiety and sleeplessness. Initial reports of suppression of growth have been placed in doubt by later studies. Dependence can occur with chronic abuse.


Bibliography

Dopelt, Keren, et al. "What Drives the Non-Medical Use of Stimulants Among College Students? The Role of Self-Efficacy and Attitudes: A Cross-Sectional Study of Israeli Undergraduates." European Journal of Investigation in Health, Psychology and Education, vol. 15, no. 7, 2025. MDPI, doi.org/10.3390/ejihpe15070141. Accessed 11 Oct. 2025.

Edinoff, Amber N., et al. "Prescription Stimulants in College and Medical Students: A Narrative Review of Misuse, Cognitive Impact, and Adverse Effects." Psychiatry International, vol. 3, no. 3, 2022, pp. 221-235. MDPI, doi.org/10.3390/psychiatryint3030018. Accessed 11 Oct. 2025.

Iversen, Leslie. Speed, Ecstasy, Ritalin: The Science of Amphetamines. Oxford UP, 2008.

Levinthal, Charles F. Drugs, Behavior, and Modern Society. 9th ed., Pearson, 2023.

"Misuse of Prescription Drugs Research Report: Overview." National Institute on Drug Abuse, 11 Oct. 2011, nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview. Accessed 11 Oct. 2025.

Mosel, Stacy. "Ritalin Addiction: Signs, Effects, and Treatment." American Addiction Centers, 20 Nov. 2024, americanaddictioncenters.org/stimulants/ritalin. Accessed 11 Oct. 2025.

Racine, Eric, and C. Forlini. “Cognitive Enhancement, Lifestyle Choice, or Misuse of Prescription Drugs?” Neuroethics, no. 3, 2010, pp. 1–4.

Rath, Kimberly. "Ritalin Side Effects: What You Should Know." MedicalNewsToday, 9 Sept. 2024, www.medicalnewstoday.com/articles/drugs-ritalin-side-effects. Accessed 11 Oct. 2025.

Raymond, Laurie. "Risks of Stimulant Misuse." Physician Health Services, Inc., www.massmed.org/Physician_Health_Services/Education_and_Resources/Risks_of_Stimulant_Misuse/. Accessed 11 Oct. 2025.

“Signs and Symptoms of Prescription Drug Use.” Narconon, www.narconon.org/drug-abuse/signs-symptoms-prescription-drug-use.html. Accessed 11 Oct. 2025.

"2023 NSDUH Annual National Report." Substance Abuse and Mental Health Services Administration, 30 July 2024, www.samhsa.gov/data/report/2023-nsduh-annual-national-report. Accessed 11 Oct. 2025.

Wilde, Cathy. "Nonprescription Use of Ritalin Linked to Adverse Side Effects, UB Study Finds." UB Now, 17 May 2017, www.buffalo.edu/ubnow/stories/2017/05/thanos-ritalin.html. Accessed 11 Oct. 2025.

More Like ThisRelated Articles

Related Articles (5)

Related Articles (5)